Paratek Pharmaceuticals
PRTK
$2.23
Share price
0.00%
Change (1 day)
15.54%
Change (1 year)
Categories
Operating Margin for Paratek Pharmaceuticals (PRTK)
Operating Margin as of May 2024 (TTM): -48.35%
According to Paratek Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -48.35%. At the end of 2021 the company had an Operating Margin of -48.35%.
Operating Margin history for Paratek Pharmaceuticals from 2004 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -48.35% | -78.2% |
| 2020 | -221.85% | -71.44% |
| 2019 | -776.65% | 18.85% |
| 2018 | -653.47% | -6.65% |
| 2017 | -700.03% | -99.82% |
| 2016 | -384,951.72% | |
| 2014 | -410.76% | -73.85% |
| 2013 | -1,571.04% | 1341.6% |
| 2012 | -108.98% | 470.2% |
| 2011 | -19.11% | -74.09% |
| 2010 | -73.78% | -80.64% |
| 2009 | -381.09% | -820.94% |
| 2008 | 52.86% | -124.06% |
| 2007 | -219.69% | -97.51% |
| 2006 | -8,825.88% | -80.12% |
| 2005 | -44,400.00% | 2548.06% |
| 2004 | -1,676.70% | -1776.7% |
| 2003 | 100.00% | -106.31% |
| 2002 | -1,584.37% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | -162.16% | 235.39% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -109.76% | 127.01% | 🇺🇸 USA |
 Agenus
AGEN | -9.71% | -79.92% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.